240 related articles for article (PubMed ID: 17595525)
1. Role of phospholamban in cyclic GMP mediated signaling in cardiac myocytes.
Zhang Q; Scholz PM; Pilzak A; Su J; Weiss HR
Cell Physiol Biochem; 2007; 20(1-4):157-66. PubMed ID: 17595525
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of cGMP produced by soluble and particulate guanylyl cyclase on mouse ventricular myocytes.
Su J; Scholz PM; Weiss HR
Exp Biol Med (Maywood); 2005 Apr; 230(4):242-50. PubMed ID: 15792945
[TBL] [Abstract][Full Text] [Related]
3. Cyclic GMP signaling and regulation of SERCA activity during cardiac myocyte contraction.
Zhang Q; Scholz PM; He Y; Tse J; Weiss HR
Cell Calcium; 2005 Mar; 37(3):259-66. PubMed ID: 15670873
[TBL] [Abstract][Full Text] [Related]
4. Increased effects of C-type natriuretic peptide on contractility and calcium regulation in murine hearts overexpressing cyclic GMP-dependent protein kinase I.
Wollert KC; Yurukova S; Kilic A; Begrow F; Fiedler B; Gambaryan S; Walter U; Lohmann SM; Kuhn M
Br J Pharmacol; 2003 Dec; 140(7):1227-36. PubMed ID: 14609817
[TBL] [Abstract][Full Text] [Related]
5. Increased effects of C-type natriuretic peptide on cardiac ventricular contractility and relaxation in guanylyl cyclase A-deficient mice.
Pierkes M; Gambaryan S; Bokník P; Lohmann SM; Schmitz W; Potthast R; Holtwick R; Kuhn M
Cardiovasc Res; 2002 Mar; 53(4):852-61. PubMed ID: 11922895
[TBL] [Abstract][Full Text] [Related]
6. Cardiac myocyte calcium transport in phospholamban knockout mouse: relaxation and endogenous CaMKII effects.
Li L; Chu G; Kranias EG; Bers DM
Am J Physiol; 1998 Apr; 274(4):H1335-47. PubMed ID: 9575939
[TBL] [Abstract][Full Text] [Related]
7. Functional effects of C-type natriuretic peptide and nitric oxide are attenuated in hypertrophic myocytes from pressure-overloaded mouse hearts.
Su J; Zhang Q; Moalem J; Tse J; Scholz PM; Weiss HR
Am J Physiol Heart Circ Physiol; 2005 Mar; 288(3):H1367-73. PubMed ID: 15550520
[TBL] [Abstract][Full Text] [Related]
8. Role of cGMP-PKG signaling in the protection of neonatal rat cardiac myocytes subjected to simulated ischemia/reoxygenation.
Gorbe A; Giricz Z; Szunyog A; Csont T; Burley DS; Baxter GF; Ferdinandy P
Basic Res Cardiol; 2010 Sep; 105(5):643-50. PubMed ID: 20349314
[TBL] [Abstract][Full Text] [Related]
9. Effects of natriuretic peptides on ventricular myocyte contraction and role of cyclic GMP signaling.
Zhang Q; Moalem J; Tse J; Scholz PM; Weiss HR
Eur J Pharmacol; 2005 Mar; 510(3):209-15. PubMed ID: 15763244
[TBL] [Abstract][Full Text] [Related]
10. Importance of ryanodine receptors in effects of cyclic GMP is reduced in thyroxine-induced cardiac hypertrophy.
Zhang Q; Goel N; Rodriguez R; Scholz PM; Weiss HR
Eur J Pharmacol; 2006 May; 537(1-3):45-51. PubMed ID: 16626695
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia inducible factor-1 improves the negative functional effects of natriuretic peptide and nitric oxide signaling in hypertrophic cardiac myocytes.
Tan T; Scholz PM; Weiss HR
Life Sci; 2010 Jul; 87(1-2):9-16. PubMed ID: 20470788
[TBL] [Abstract][Full Text] [Related]
12. Neuronal nitric oxide synthase signaling within cardiac myocytes targets phospholamban.
Wang H; Kohr MJ; Traynham CJ; Wheeler DG; Janssen PM; Ziolo MT
Am J Physiol Cell Physiol; 2008 Jun; 294(6):C1566-75. PubMed ID: 18400986
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide donors alter cardiomyocyte cytokine secretion and cardiac function.
Maass DL; White J; Horton JW
Crit Care Med; 2005 Dec; 33(12):2794-803. PubMed ID: 16352962
[TBL] [Abstract][Full Text] [Related]
14. Alterations in ventricular myocyte contraction caused by C-type natriuretic peptide and nitric oxide in eNOS-/- mice.
Su J; Tse J; Scholz PM; Weiss HR
J Mol Cell Cardiol; 2005 Dec; 39(6):920-8. PubMed ID: 16236310
[TBL] [Abstract][Full Text] [Related]
15. Alterations in nitric oxide-cGMP pathway in ventricular myocytes from obese leptin-deficient mice.
Su J; Zhang S; Tse J; Scholz PM; Weiss HR
Am J Physiol Heart Circ Physiol; 2003 Nov; 285(5):H2111-7. PubMed ID: 12869380
[TBL] [Abstract][Full Text] [Related]
16. SERCA2 activity is involved in the CNP-mediated functional responses in failing rat myocardium.
Moltzau LR; Aronsen JM; Meier S; Nguyen CH; Hougen K; Ørstavik Ø; Sjaastad I; Christensen G; Skomedal T; Osnes JB; Levy FO; Qvigstad E
Br J Pharmacol; 2013 Sep; 170(2):366-79. PubMed ID: 23808942
[TBL] [Abstract][Full Text] [Related]
17. Phospholamban is required for CaMKII-dependent recovery of Ca transients and SR Ca reuptake during acidosis in cardiac myocytes.
DeSantiago J; Maier LS; Bers DM
J Mol Cell Cardiol; 2004 Jan; 36(1):67-74. PubMed ID: 14734049
[TBL] [Abstract][Full Text] [Related]
18. Effects of cyclic GMP and its protein kinase on the contraction of ventricular myocytes from hearts after cardiopulmonary arrest.
Su J; Scholz PM; Tse J; Weiss HR
Can J Physiol Pharmacol; 2004 Nov; 82(11):986-92. PubMed ID: 15644938
[TBL] [Abstract][Full Text] [Related]
19. CaM kinase II activation and phospholamban phosphorylation by SNP in murine gastric antrum smooth muscles.
Kim M; Perrino BA
Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1045-54. PubMed ID: 17185633
[TBL] [Abstract][Full Text] [Related]
20. SERCA inhibition limits the functional effects of cyclic GMP in both control and hypertrophic cardiac myocytes.
Zhang Q; Davidov T; Weiss HR; Scholz PM
Pharmacology; 2009; 83(4):223-30. PubMed ID: 19258738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
